In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Vir Biotechnology Inc’s stock clocked out at $6.18, down -4.63% from its previous closing price of $6.48. In other words, the price has decreased by -$4.63 from its previous closing price. On the day, 1.76 million shares were traded. VIR stock price reached its highest trading level at $6.65 during the session, while it also had its lowest trading level at $6.15.
Ratios:
To gain a deeper understanding of VIR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.71 and its Current Ratio is at 8.71. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $23 previously.
On September 08, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $23 to $14.
JP Morgan Upgraded its Neutral to Overweight on March 06, 2023, whereas the target price for the stock was revised from $35 to $34.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 26 ’25 when de Verneuil Vanina sold 7,373 shares for $9.14 per share. The transaction valued at 67,402 led to the insider holds 79,460 shares of the business.
VANINA DE VERNEUIL bought 7,373 shares of VIR for $67,094 on Feb 26 ’25. On Feb 24 ’25, another insider, SCANGOS GEORGE A, who serves as the Director of the company, sold 10,056 shares for $9.45 each. As a result, the insider received 95,063 and left with 698,239 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VIR now has a Market Capitalization of 847543744 and an Enterprise Value of 40088508. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.42 while its Price-to-Book (P/B) ratio in mrq is 0.74. Its current Enterprise Value per Revenue stands at 0.54 whereas that against EBITDA is -0.079.
Stock Price History:
The Beta on a monthly basis for VIR is 1.14, which has changed by -0.3622291 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, VIR has reached a high of $14.45, while it has fallen to a 52-week low of $6.25. The 50-Day Moving Average of the stock is -28.64%, while the 200-Day Moving Average is calculated to be -27.37%.
Shares Statistics:
It appears that VIR traded 2.08M shares on average per day over the past three months and 1417350 shares per day over the past ten days. A total of 136.96M shares are outstanding, with a floating share count of 87.38M. Insiders hold about 36.28% of the company’s shares, while institutions hold 51.31% stake in the company. Shares short for VIR as of 1741910400 were 7880284 with a Short Ratio of 3.78, compared to 1739491200 on 7670907. Therefore, it implies a Short% of Shares Outstanding of 7880284 and a Short% of Float of 9.35.
